Clinical Trials Logo
  1. Home
  2. Cervical Intraepithelial Neoplasia
  3. NCT04484415

Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL) — APRICITY  

Cervical Intraepithelial Neoplasia Grade 2/3 Clinical Trial

Official title:
A Double Blind, Prospective, Randomized, Placebo Controlled, Multi-center Phase 3 Study to Evaluate Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL)

Clinical Trial Summary

A double blind, prospective, randomized, placebo controlled, multi-center phase 3 study to evaluate efficacy and safety of Cevira® in patients with cervical histologic high-grade squamous intraepithelial lesions (HSIL).

Clinical Trial Description

To evaluate the efficacy and safety of Cevira® compared to placebo in treatment of patients with cervical histologic HSIL.A total of 384 subjects will be enrolled globally, among which, 300 subjects of them will be enrolled in China. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04484415
Study type Interventional
Source Jiangsu Yahong Meditech Co., Ltd aka Asieris
Contact
Status Active, not recruiting
Phase Phase 3
Start date November 10, 2020
Completion date December 2023
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03196180 - Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia Early Phase 1
Not yet recruiting NCT06258564 - The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization
Recruiting NCT04788849 - Extended VALidation of HUman Papillomavirus Assays and Collection DEvices for HPV Testing on Self-samples
Not yet recruiting NCT06273553 - A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3 Phase 1/Phase 2
Active, not recruiting NCT02149030 - Effectiveness of Cervical Screening in HPV Vaccinated Women Phase 4
Completed NCT01550783 - Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening N/A
Enrolling by invitation NCT04755517 - Effectiveness of Cervical Screening in Unvaccinated, Herd Effect Protected Women (HPV400) N/A
Completed NCT02811367 - The HPV Self-test as a Test of Cure in Madagascar N/A
Completed NCT00081263 - Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia Phase 2
Recruiting NCT05405270 - Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Completed NCT04312737 - Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma Virus
Completed NCT02067468 - Optimal Strategy for the Management of ASCUS Cytology in Health Care Services of Medellin, Colombia N/A
Completed NCT02354534 - Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3) Phase 1
Recruiting NCT03366493 - The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection Phase 3
Active, not recruiting NCT03064087 - Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples
Recruiting NCT05851079 - Accurate Screening and Prevention of Cervical Lesions-- Development of Accurate Screening Methods for Cervical Lesions
Recruiting NCT03274206 - A Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3) Phase 2